BCPC FINANCIAL STATEMENTS

Balchem Corporation — balance sheet, income statement and cash flow trends

BCPCBalchem Corporation

🇺🇸 USA · NASDAQ · Basic Materials · Specialty Chemicals

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue1.1 B $+9.6%

Gross Profit383.5 M $+11.9%

Operating Income221.7 M $+15.3%

EBITDA270.7 M $+14.2%

Net Income158.1 M $+15.8%

Peer Comparison· Specialty Chemicals

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
BCPC	9.6%	36.3%	25.6%	15.0%
IMCD	1.2%	17.7%	10.9%	4.5%
DNL	-16.6%	27.9%	17.8%	4.5%
ORI	1.8%	19.2%	17.3%	3.1%
BNR	-9.5%	18.6%	7.9%	1.5%
AKZA	-7.0%	40.1%	16.0%	6.3%
Industry median	1.2%	26.7%	14.7%	3.5%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
BCPC	9.6%	36.3%	25.6%	15.0%
SXT	5.8%	33.8%	17.0%	8.7%
PRM	23.0%	53.1%	-18.7%	-26.9%
CBT	-8.5%	25.0%	21.1%	8.0%
NEU	-3.5%	31.3%	26.4%	15.3%
AXTA	-2.6%	32.2%	19.7%	7.2%
Industry median	1.2%	26.7%	14.7%	3.5%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity1.3 B $76%
Current Liabilities152.5 M $9%
Long-term Liabilities256.1 M $15%

Key Figures

YoY change

Total Assets1.7 B $+4.7%

Total Liabilities408.6 M $-0.1%

Total Equity1.3 B $+6.3%

Cash & ST Investments72.9 M $+46.0%

Total Debt184.7 M $-11.2%

Net Debt111.8 M $-29.3%

Peer Comparison· Specialty Chemicals

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
BCPC	2.55	14.4%	0.41	75.9%
IMCD	1.73	83.4%	2.81	44.0%
DNL	1.27	39.7%	2.15	57.8%
ORI	1.31	86.9%	1.77	38.5%
BNR	1.74	75.4%	2.31	40.0%
AKZA	1.72	125.2%	1.94	31.5%
Industry median	1.87	63.0%	2.15	46.9%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
BCPC	2.55	14.4%	0.41	75.9%
SXT	5.01	63.0%	2.59	53.3%
PRM	3.09	113.4%	-9.65	38.1%
CBT	1.45	82.8%	1.39	40.2%
NEU	2.55	58.9%	1.33	49.4%
AXTA	2.10	130.0%	2.53	32.0%
Industry median	1.87	63.0%	2.15	46.9%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow220.2 M $+19.0%

Capital Expenditures44.2 M $+28.8%

Free Cash Flow176 M $+16.7%

Dividends Paid-30.8 M $-208.9%

Peer Comparison· Specialty Chemicals

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
BCPC	20.8%	16.6%	4.2%	139.3%
IMCD	6.7%	6.5%	0.3%	148.1%
DNL	9.3%	-0.2%	9.5%	205.3%
ORI	11.6%	6.2%	5.4%	372.9%
BNR	6.4%	4.4%	2.0%	415.2%
AKZA	9.6%	6.6%	3.0%	153.9%
Industry median	9.6%	5.8%	5.0%	111.7%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
BCPC	20.8%	16.6%	4.2%	139.3%
SXT	7.4%	1.3%	6.1%	85.4%
PRM	18.7%	12.2%	6.5%	-69.5%
CBT	18.8%	12.8%	5.9%	235.4%
NEU	21.3%	18.0%	3.3%	139.4%
AXTA	13.5%	9.6%	4.0%	187.0%
Industry median	9.6%	5.8%	5.0%	111.7%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BCPC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.